#VisualAbstract: Early versus later anticoagulation for stroke with atrial fibrillation
Bookmark Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights...
Read MoreJun 7, 2023
Bookmark Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights...
Read MoreJun 7, 2023
Bookmark1. Although anemia prevalence at 36 weeks was slightly lower in the ferric carboxymaltose...
Read MoreJun 7, 2023
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read MoreJun 3, 2023
Bookmark 1. Annualized bleeding rate was reduced by 91% in the fitusiran prophylaxis group...
Read MoreJun 2, 2023
Bookmark Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read MoreJun 2, 2023
Bookmark 1. The price increase of Colchicine in the United States led to greater use of...
Read MoreJun 2, 2023
Bookmark Patients in sparsentan group reported a 50% reduction in proteinuria compared to...
Read MoreJun 2, 2023
Bookmark 1. Patients in the high-dose dexamethasone group reported significantly greater mortality...
Read MoreMay 31, 2023
Bookmark Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read MoreMay 27, 2023
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read MoreMay 27, 2023
BookmarkClick here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved....
Read MoreMay 21, 2023
Bookmark1. In this randomized controlled trial, respiratory syncytial virus prefusion F...
Read MoreMay 9, 2023
BookmarkClick here to read this study in JAMA
Read MoreMay 6, 2023
BookmarkClick here to read this study in NEJM
Read MoreMay 3, 2023
Click to read this study in JAMA Network Open.
Read MoreApr 24, 2023
1. In both ELEVATE UC 12 and ELEVATE UC 52, significantly greater patients in the etrasimod group...
Read MoreApr 24, 2023
1. In asymptomatic patients, subclinical coronary atherosclerosis was associated with an...
Read MoreApr 7, 2023
Click to read this study in The Lancet Oncology.
Read MoreMar 31, 2023
1. In this randomized controlled trial, among patients with recurrent kidney stones,...
Read MoreMar 26, 2023
1. Patients receiving secukinumab every 2-weeks showed superior clinical response rates compared...
Read More